Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Radiotherapy × Dermatologic × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 34 Lymphoma, T-Cell, Cutaneous 15 Sezary Syndrome 14 Mycosis Fungoides 14 Lymphoma, Non-Hodgkin 12 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, Follicular 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Large-Cell, Immunoblastic 11 Lymphoma, B-Cell, Marginal Zone 11 Hodgkin Disease 11 Lymphoma, Mantle-Cell 10 Lymphoma 10 Burkitt Lymphoma 10 Recurrence 8 Leukemia, Myeloid, Acute 8 Carcinoma, Merkel Cell 8 Breast Neoplasms 8 Skin Neoplasms 7 Multiple Myeloma 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia, Hairy Cell 7 Dendritic Cell Sarcoma, Interdigitating 7 Primary Myelofibrosis 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Myeloproliferative Disorders 6 Myelodysplastic Syndromes 6 Leukemia, Myelomonocytic, Chronic 6

Interventions

Ipilimumab 25 Nivolumab 19 pembrolizumab 11 incomplete Freund's adjuvant 10 Melphalan 9 Cyclophosphamide 9 Interleukin-2 8 sargramostim 7 MART-1 Antigen 7 CTLA-4 Antigen 7 tebentafusp 6 Temozolomide 6 Ranibizumab 6 montanide ISA 51 5 Sunitinib 5 Radiosurgery 5 Dacarbazine 5 Blood Specimen Collection 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Carboplatin 4 Biopsy 4 Bevacizumab 4 trametinib 3 sotrastaurin 3 fludarabine phosphate 3 fludarabine 3 binimetinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡